Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
55.6M
-
Number of holders
-
240
-
Total 13F shares, excl. options
-
65.2M
-
Shares change
-
+1.4M
-
Total reported value, excl. options
-
$10.1B
-
Value change
-
+$223M
-
Put/Call ratio
-
1.5
-
Number of buys
-
128
-
Number of sells
-
-109
-
Price
-
$155.86
Significant Holders of Ascendis Pharma A/S - ADR (ASND) as of Q1 2025
277 filings reported holding ASND - Ascendis Pharma A/S - ADR as of Q1 2025.
Ascendis Pharma A/S - ADR (ASND) has 240 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 65.2M shares
.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (10.3M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (5.48M shares), Avoro Capital Advisors LLC (5.22M shares), FMR LLC (4.67M shares), JANUS HENDERSON GROUP PLC (4.49M shares), Artisan Partners Limited Partnership (4.26M shares), T. Rowe Price Investment Management, Inc. (3.05M shares), Capital International Investors (2.87M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.26M shares), and MORGAN STANLEY (1.9M shares).
This table shows the top 240 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.